Polen Focus Growth ETF
PCLG · ETF
About PCLG
- Issuer
- Polen
- Expense ratio
- 0.49%
- Assets under management
- $91.11M
- Inception
- Sep 30, 2025
- Asset class
- Equity
- Website
- polencapital.com
PCLG key statistics
- Price-earnings ratio
- 0.00
- Average volume
- 4.75K
- Volume
- 3.88K
- Open price
- $22.73
- High today
- $22.80
- Low today
- $22.66
- 52 Week high
- $25.89
- 52 Week low
- $19.73
Polen Focus Growth ETF (PCLG) at a glance
As of Oct 23, 2026, Polen Focus Growth ETF (PCLG) shares are priced at $22.69, giving the company a price-to-earnings ratio of 0.00.
Today the fund has traded between $22.66 and $22.80. The current price is 0.1% above the day's low and 0.5% below its high.
Volume so far is 3.88K shares, in line with the average of 4.75K shares a day.
Over the past year Polen Focus Growth ETF has ranged from $19.73 to $25.89, and now sits 48% of the way up that range.
PCLG news
- Kaustubh Bagalkote
- Vandana Singh
Eli Lilly Jumps As Earnings Beat Meets FDA Tightening Drug Compounding Rules
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0002+0.00%
- GTVHGolden Triangle Ventures$0.0002+100.00%
- TMSHTrans Global Assets$0.0003+20.00%
- RDARRaadr$0.0002+0.00%
- GPUSHyperscale Data$0.1689+34.05%
- SEIISharing Economy International$0.0002−33.33%
- ELMEElme Communities$1.77+0.57%
- SHFSSHF Holdings$0.1324−61.39%
- XXII22nd Century Group$0.1977−8.34%
- NBNDNetBrands$0.0006−40.00%
- NVDGraniteShares ETF Trust$4.19+0.96%
- HIRUHiru$0.0006+9.09%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.49−0.10%
- CTYCITY THERAPEUTICS$20.77+0.00%
- IAMIambic Therapeutics$14.26−2.79%
- AMROAmaero$5.84+7.75%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.30+0.29%
- TRXBTRex Bio$13.81−10.90%
- RTSNRetension Pharmaceuticals$15.25−1.61%
- PAXGUPine Tree Acquisition$10.01+0.05%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.13−0.77%
- ACCVAccelevation Holdings$12.38+1.06%
- RZAIROZE AI$10.92−1.89%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.